| Rachael Elizabeth Zanotti-morocco, DO | |
|
2295 W William St, Delaware, OH 43015-1361 | |
| (740) 615-0300 | |
| Not Available |
| Full Name | Rachael Elizabeth Zanotti-morocco |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 2295 W William St, Delaware, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609038744 | NPI | - | NPPES |
| 0066047 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 34.010098 (Ohio) | Primary |
| Entity Name | Ohiohealth Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545273 PECOS PAC ID: 6305758426 Enrollment ID: O20031105000532 |
News Archive
The U.S. Food and Drug Administration today expanded the approval of a heart valve to include a size small enough to be used in newborn pediatric patients to treat heart defects. Specifically, the agency approved the Masters Series Mechanical Heart Valve with Hemodynamic Plus Sewing Cuff to include the 15-mm valve size, making it the smallest mechanical heart valve approved in the world.
Researchers at St. Michael's Hospital in Toronto are part of an international team of researchers recently awarded a multi-million dollar grant for their work in cardiovascular disease among Indigenous people in Canada, Australia and New Zealand. The Canadian team will receive $742,000 in funding for its part of the project from the Canadian Institutes of Health Research and International Collaborative Indigenous Health Research Partnerships.
A team of Israeli and American researchers have found that silicon nanomaterials used for the localized delivery of chemotherapy drugs behave differently in cancerous tumors than they do in healthy tissues. The findings could help scientists better design such materials to facilitate the controlled and targeted release of the chemotherapy drugs to tumors.
During its research into the application of neuroscience in business, a New Jersey based think tank, The Center for Modeling Optimal Outcomes®, LLC (The Center) made an inadvertent and amazing discovery.
A new deep learning algorithm created by researchers from the University of Warwick can pick up the molecular pathways and development of key mutations causing colorectal cancer more accurately than existing methods, meaning patients could benefit from targeted therapies with quicker turnaround times and at a lower cost.
› Verified 1 days ago
| Entity Name | Pediatric Academic Association, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063419943 PECOS PAC ID: 2961306774 Enrollment ID: O20031124000198 |
News Archive
The U.S. Food and Drug Administration today expanded the approval of a heart valve to include a size small enough to be used in newborn pediatric patients to treat heart defects. Specifically, the agency approved the Masters Series Mechanical Heart Valve with Hemodynamic Plus Sewing Cuff to include the 15-mm valve size, making it the smallest mechanical heart valve approved in the world.
Researchers at St. Michael's Hospital in Toronto are part of an international team of researchers recently awarded a multi-million dollar grant for their work in cardiovascular disease among Indigenous people in Canada, Australia and New Zealand. The Canadian team will receive $742,000 in funding for its part of the project from the Canadian Institutes of Health Research and International Collaborative Indigenous Health Research Partnerships.
A team of Israeli and American researchers have found that silicon nanomaterials used for the localized delivery of chemotherapy drugs behave differently in cancerous tumors than they do in healthy tissues. The findings could help scientists better design such materials to facilitate the controlled and targeted release of the chemotherapy drugs to tumors.
During its research into the application of neuroscience in business, a New Jersey based think tank, The Center for Modeling Optimal Outcomes®, LLC (The Center) made an inadvertent and amazing discovery.
A new deep learning algorithm created by researchers from the University of Warwick can pick up the molecular pathways and development of key mutations causing colorectal cancer more accurately than existing methods, meaning patients could benefit from targeted therapies with quicker turnaround times and at a lower cost.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachael Elizabeth Zanotti-morocco, DO Po Box 7527, Dublin, OH 43017-0727 Ph: () - | Rachael Elizabeth Zanotti-morocco, DO 2295 W William St, Delaware, OH 43015-1361 Ph: (740) 615-0300 |
News Archive
The U.S. Food and Drug Administration today expanded the approval of a heart valve to include a size small enough to be used in newborn pediatric patients to treat heart defects. Specifically, the agency approved the Masters Series Mechanical Heart Valve with Hemodynamic Plus Sewing Cuff to include the 15-mm valve size, making it the smallest mechanical heart valve approved in the world.
Researchers at St. Michael's Hospital in Toronto are part of an international team of researchers recently awarded a multi-million dollar grant for their work in cardiovascular disease among Indigenous people in Canada, Australia and New Zealand. The Canadian team will receive $742,000 in funding for its part of the project from the Canadian Institutes of Health Research and International Collaborative Indigenous Health Research Partnerships.
A team of Israeli and American researchers have found that silicon nanomaterials used for the localized delivery of chemotherapy drugs behave differently in cancerous tumors than they do in healthy tissues. The findings could help scientists better design such materials to facilitate the controlled and targeted release of the chemotherapy drugs to tumors.
During its research into the application of neuroscience in business, a New Jersey based think tank, The Center for Modeling Optimal Outcomes®, LLC (The Center) made an inadvertent and amazing discovery.
A new deep learning algorithm created by researchers from the University of Warwick can pick up the molecular pathways and development of key mutations causing colorectal cancer more accurately than existing methods, meaning patients could benefit from targeted therapies with quicker turnaround times and at a lower cost.
› Verified 1 days ago
Emily Sentman, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 7853 Pacer Dr, Delaware, OH 43015 Phone: 614-355-7900 | |
David Robert Stukus, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 7853 Pacer Dr, Delaware, OH 43015 Phone: 614-722-6200 | |
Elizabeth Anne Claxton, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 7853 Pacer Dr, Delaware, OH 43015 Phone: 614-355-7900 | |
Gregory B Stewart, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 7853 Pacer Dr, Delaware, OH 43015 Phone: 614-355-7900 | |
Blake Randolph, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 7420 Gooding Blvd, Delaware, OH 43015 Phone: 740-657-8000 | |
Dr. Natalie Ann Dick, D.O. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 801 Ohiohealth Blvd, Ste 200, Delaware, OH 43015 Phone: 740-615-0270 Fax: 740-615-0279 | |
Stephen L Schuler, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 104 N Union St Ste B, Delaware, OH 43015 Phone: 740-362-3696 Fax: 740-362-5010 |